Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate that heated, humidified, high-flow nasal cannula (HHHFNC) is superior to hypertonic saline solution (HSS) in the treatment of moderate acute viral bronchiolitis in infants in improving respiratory distress and comfort and reducing length of hospital stay (LOS) and admission to Pediatric Intensive Care Unit (PICU).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01873144
Study type Interventional
Source Ministry of Health, Spain
Contact
Status Completed
Phase Phase 3
Start date October 2010
Completion date December 2012

See also
  Status Clinical Trial Phase
Completed NCT01777347 - Efficacy of 3% Hypertonic Saline in Acute Viral Bronchiolitis Phase 3
Not yet recruiting NCT01437956 - KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis N/A
Completed NCT05899894 - NAVA in Infants With Acute Viral Bronchiolitis: A Feasibility Study N/A
Completed NCT02460614 - Effects of Rhinopharyngeal Retrograde Clearance in Children With Acute Viral Bronchiolitis N/A
Completed NCT03738501 - Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis N/A
Recruiting NCT03976895 - Prone Position in Acute Bronchiolitis N/A
Active, not recruiting NCT01295398 - Influence of the Nebulizer on the Clinical Efficacy of Hypertonic Saline 3% in Children Aged Less Than 18 Months and Hospitalized With Acute Viral Bronchiolitis N/A